26 completed, 4 terminated, 2 unknown. 32 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 32 | Completed 26, Terminated 4, Unknown 2 |
Follow Secondary Hyperparathyroidism: new trials by email Literature Review of Secondary Hyperparathyroidism trials Research Report on Secondary Hyperparathyroidism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis Patients cardiac MRI, echocardiography with strain, Laboratory tests - Secondary Hyperparathyroidism, Chronic Kidney Disease Requiring Chronic Dialysis | Phase 4 | Completed | Rainer Oberbauer | 62 | 2017-10-01 | 2020-06-09 |
| Cinacalcet in Management of Secondary Hyperparathyroidism in Haemodialysis Patients Combination Cinacalcet with Vitamin D analogue - Secondary Hyperparathyroidism | Phase 4 | Unknown | Penang Hospital, Malaysia | 30 | 2015-01-01 | 2015-01-14 |
| Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol Calcitriol, Paricalcitol - Kidney Failure, Secondary Hyperparathyroidism | Phase 4 | Terminated | Winthrop University Hospital | 16 | 2012-11-01 | 2023-11-07 |
| Intravenous Paricalcitol in Chronic Hemodialysis Patients Intravenous Paricalcitol - Endstage Renal Disease, Secondary Hyperparathyroidism | Phase 4 | Unknown | The University of Hong Kong | 30 | 2011-09-01 | 2017-01-18 |
| Cinacalcet stUdy for Peritoneal Dialysis Patients In Double Arm on the Lowing Effect OF iPTH Level cinacalcet, control - Secondary Hyperparathyroidism | Phase 4 | Completed | Seoul National University Hospital | 66 | 2010-09-01 | 2012-06-08 |
| Cinacalcet Versus Parathyroidectomy in Peritoneal Dialysis Patients Cinacalcet, Surgical total parathyroidectomy with forearm autografting - Kidney Failure, Secondary Hyperparathyroidism | Phase 4 | Completed | The University of Hong Kong | 67 | 2010-05-10 | 2021-10-12 |
| Trial to Optimize Mineral Outcomes in Dialysis Patients Cinacalcet, active vitamin D analogue - Secondary Hyperparathyroidism, Chronic Kidney Disease | Phase 4 | Completed | University of Colorado, Denver | 92 | 2010-03-01 | 2017-01-02 |
| Vitamin D Status in Males in Jerusalem Area and Its Correlation to Parathyroid Hormone (PTH) Level and Bone Mineral Density 25 OH vitamin D - Vitamin D Deficiency, Secondary Hyperparathyroidism | Phase 4 | Completed | Clalit Health Services | 210 | 2010-01-01 | 2014-07-21 |
| Parathyroidectomy vs Cinacalcet in the Treatment of Secondary Hyperparathyroidism Post Renal Transplantation Subtotal parathyroidectomy, Cinacalcet - Secondary Hyperparathyroidism | Phase 4 | Completed | Josep M Cruzado | 30 | 2010-01-01 | 2015-04-28 |
| Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D Paricalcitol, Cinacalcet - Chronic Kidney Disease, Secondary Hyperparathyroidism | Phase 4 | Completed | Abbott | 272 | 2009-11-01 | 2012-06-20 |
| Vitamin D Deficiency in Chronic Kidney Disease (CKD) Patients Paricalcitol, Ergocalciferol - Secondary Hyperparathyroidism, Chronic Kidney Disease | Phase 4 | Completed | Salem Veterans Affairs Medical Center | 80 | 2009-07-01 | 2011-03-24 |
| Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial Dose Zemplar (paricalcitol) - Secondary Hyperparathyroidism, Renal Insufficiency, Chronic | Phase 4 | Completed | Abbott | 100 | 2009-05-01 | 2011-10-31 |
| Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT) Paricalcitol, Calcitriol - Secondary Hyperparathyroidism, Chronic Kidney Disease | Phase 4 | Completed | Washington University School of Medicine | 110 | 2009-02-01 | 2014-08-07 |
| 20070360 Incident Dialysis Cinacalcet, Vitamin D - Chronic Kidney Disease, Secondary Hyperparathyroidism | Phase 4 | Completed | Amgen | 313 | 2009-02-01 | 2018-10-17 |
| Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects Calcitriol, Paricalcitol - Secondary Hyperparathyroidism, Dialysis | Phase 4 | Terminated | Abbott | 13 | 2009-01-01 | 2012-01-20 |
| Efficacy and Safety of Alfacalcidol Compared to Calcitriol for Treatment of Secondary Hyperparathyroidism alfacalcidol and calcitriol - Secondary Hyperparathyroidism, End Stage Renal Disease | Phase 4 | Completed | Mahidol University | 32 | 2008-08-01 | 2010-05-04 |
| Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral in Patients With Secondary Hyperparathyroidism on Dialysis Paricalcitol injection, Paricalcitol capsules - Secondary Hyperparathyroidism, Dialysis | Phase 4 | Completed | Abbott | 147 | 2007-09-01 | 2011-10-25 |
| A Phase 4 Study to Determine Dosing of Hectorol® Capsules When Converting From Zemplar® Injection Hectorol (doxercalciferol capsules), Zemplar (paricalcitol injection) - Secondary Hyperparathyroidism | Phase 4 | Completed | Genzyme, a Sanofi Company | 36 | 2007-04-01 | 2015-05-05 |
| A Phase 4 Pharmacokinetic Study of Hectorol Injection and Zemplar Injection in CKD Subjects on Hemodialysis Hectorol (doxercalciferol injection), Zemplar (Paricalcitol injection) - Secondary Hyperparathyroidism | Phase 4 | Completed | Genzyme, a Sanofi Company | 12 | 2007-02-01 | 2015-05-05 |
| A Phase 4, Conversion Study of Hectorol® Injection to Hectorol® Capsules in Stage 5 CKD Patients on Dialysis Hectorol® (doxercalciferol capsules), doxercalciferol capsules, Hectorol®, doxercalciferol capsules, Hectorol® capsules - Secondary Hyperparathyroidism | Phase 4 | Completed | Genzyme, a Sanofi Company | 36 | 2006-11-01 | 2015-03-19 |
Showing 20 of 32. Sign in to see all of them.
Hyperparathyroidism, Secondary (32) · Renal Insufficiency, Chronic (14) · Hypercalcemia (5) · Kidney Failure, Chronic (4) · Renal Insufficiency (3) · Vitamin D Deficiency (3) · Hyperparathyroidism (2) · Hyperphosphatemia (2) · Hypertrophy, Left Ventricular (2) · Kidney Diseases (2) · Vascular Calcification (2) · Anemia (1) · Calcinosis (1) · Cardiovascular Diseases (1) · Obesity (1)
Endocrine System Diseases (32) · Parathyroid Diseases (32) · Hyperparathyroidism (30) · Pathological Conditions, Signs and Symptoms (18) · Female Urogenital Diseases (17) · Female Urogenital Diseases and Pregnancy Complications (17) · Male Urogenital Diseases (17) · Urogenital Diseases (17) · Urologic Diseases (17) · Chronic Disease (16) · Disease Attributes (16) · Pathologic Processes (16) · Kidney Diseases (15) · Renal Insufficiency (14) · Nutritional and Metabolic Diseases (10)
paricalcitol (16) · Cinacalcet (11) · 1 alpha-hydroxyergocalciferol (8) · Calcitriol (6) · Vitamin D (3) · Ergocalciferols (2) · Cholecalciferol (1) · Clinical Laboratory Techniques (1) · Echocardiography (1) · Parathyroidectomy (1) · alfacalcidol (1)
Abbott (7) · Amgen (5) · Genzyme, a Sanofi Company (4) · Papageorgiou General Hospital (2) · The University of Hong Kong (2) · Clalit Health Services (1) · Josep M Cruzado (1) · Mahidol University (1) · Penang Hospital, Malaysia (1) · Per Ivarsen (1) · Rainer Oberbauer (1) · Salem Veterans Affairs Medical Center (1) · Seoul National University Hospital (1) · University of Colorado, Denver (1) · Washington University School of Medicine (1)
United States (13) · Denmark (2) · Greece (2) · Hong Kong (2) · Spain (2) · Austria (1) · Brazil (1) · Czechia (1) · Germany (1) · Israel (1) · Italy (1) · Malaysia (1) · Mexico (1) · Netherlands (1) · Peru (1)
Efstathios Mitsopoulos, MD (2) · Anat Tsur, MD (1) · Angela YM Wang, MD PhD (1) · Angela YM Wang, MD, PhD (1) · Csaba P. Kovesdy, M.D. (1) · Daniel W Coyne, MD (1) · David M Spiegel, MD (1) · Emily M Stein, M.D. (1) · Josep M Cruzado, MD (1) · Laura Williams, M.D. (1) · Lino Rodrigues, MD (1) · Matthias Lorenz, Priv.Doz. (1)
PMID 19018785, PMID 22387567, PMID 23705925, PMID 24214232, PMID 24500308, PMID 24970869, PMID 31651370, PMID 33825489, PMID 35559350, PMID 35872799, PMID 36869794, PMID 37729887, PMID 37932788, PMID 38040277
2008 (1), 2009 (1)